Larson Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Larson Financial Group's IBB Position: Q3 2026 in Review
Larson Financial Group increased its iShares Biotechnology ETF (IBB) stake by 36% in Q3 2026, buying an estimated $235K and bringing the position to 4,434 shares worth $933K. The position accounts for 0.02% of the portfolio, ranked #390.
Larson Financial Group first reported a position in IBB in Q4 2018 and has held it in 32 quarters since. 1,027 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Larson Financial Group held 4,434 shares of iShares Biotechnology ETF worth $933K as of Q3 2026.
- Larson Financial Group bought 1,170 iShares Biotechnology ETF shares in Q3 2026, an estimated $235K.
- iShares Biotechnology ETF made up 0.02% of Larson Financial Group's portfolio in Q3 2026, its #390 holding.
- Larson Financial Group first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 32 quarters since.
- 1,027 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.